Phosphoinositide 3-kinase-based dual-target inhibitors for cancer therapy: rational design, structure-activity relationships and biological evaluation: Review paper. ADMET DMPK [Internet]. 2026 Nov. 2 [cited 2026 Nov. 2];14. Available from: https://pub.iapchem.org/ojs/index.php/admet/article/view/3693